Medilayse.me

Company Overview

Snapshot

Founded in March 2016 by Daniel Leites, Maxim Razumovsky, Gali Feder, Zeev Wigelman, and Samion Buchas, Medilayse.me operates with 1–10 employees. The company ceased operations in December 2018.

Business overview

Medilayse.me develops multidisciplinary technology focused on improving geriatric care and patient safety. Its core offering is a cloud-based software that integrates cloud-computing tools like classification, association analysis, and clustering with evidence-based models such as severity of illness and frailty index. This system processes raw data from various IoT monitoring technologies to provide actionable insights, including patient quality of care (continuity of care, scheduling) and safety (early warning signs for physical and mental deterioration), summarized into a single numeric indicator. The company operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare and medical decision support markets.

Company Intelligence Q&A

What is Medilayse.me's primary focus?

Medilayse.me focuses on developing multidisciplinary technology to improve the quality of geriatric care and enhance patient safety through cloud-based software and IoT monitoring.

When was Medilayse.me founded?

Medilayse.me was founded in March 2016.

What is the operational status of Medilayse.me?

Medilayse.me is non-active and ceased to operate in December 2018.

Who are the founders of Medilayse.me?

The co-founders of Medilayse.me are Daniel Leites, Maxim Razumovsky, Gali Feder, Zeev Wigelman, and Samion Buchas.

What technology does Medilayse.me utilize?

Medilayse.me utilizes cloud-computing tools, evidence-based models, and data from various IoT monitoring technologies to provide actionable insights for geriatric care.